At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
06998 GENOR
Trading 01-02 15:32:14
2.890
-0.110
-3.67%
High3.000
Low2.840
Vol908.50K
Open2.970
D1 Closing3.000
Amplitude5.33%
Mkt Cap5.81B
Tradable Cap5.81B
Total Shares2.01B
T/O2.64M
T/O Rate0.05%
Tradable Shares2.01B
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Genor Biopharma Completes Reverse Merger Transaction With Edding Group
Genor Biopharma Holdings Ltd is a company primarily engaged in the biopharmaceuticals business. The Company’s main business is engaged in the discovery, development and commercialization of biopharmaceutical products for human use. The Company’s product pipelines include Lerociclib (GB491), GB261, GB263T, Infliximab (GB242), Coprelotamab (GB221), GB223, Rituximab (GB241) and other products, covering disease fields such as breast cancer, lung cancer, gastrointestinal tumors, and blood tumors. The Company mainly conducts its business in the domestic market.